Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant adeno-associated virus vectors to target medullary thyroid carcinoma

Recombinant adeno-associated virus vectors to target medullary thyroid carcinoma

US Patent 11266748 · Granted Mar 8, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Knee replacement implant having stackable spacers2025
Capsid-modified rAAV vector compositions and methods therefor2025
High-transduction-efficiency rAAV vectors, compositions, and methods of use2024
Myelination stimulator compounds, and methods of treatment2024
Chimeric antigen receptors and uses thereof2023
High-transduction-efficiency rAAV vectors, compositions, and methods of use2022
AAV production using suspension adapted cells2021
Subsea well equipment landing indicator and locking indicator2021
AAV vectors with high transduction efficiency and uses thereof for gene therapy2021
Hairpin MRNA elements and methods for the regulation of protein translation2021
Capsid-modified, RAAV3 vector compositions and uses in gene therapy of human liv2021
Recombinant AAV1, AAV5, and AAV6 capsid mutants and uses thereof2021